• 1
    Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators [see comments]. N Engl J Med 1998; 338:853860.
  • 2
    Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, et al. AIDS across Europe, 1994-98: The EuroSIDA study. Lancet 2000; 356:291296.
  • 3
    Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993; 167:6671.
  • 4
    Soriano V, Garcia-Samaniego J, Rodriguez-Rosado R, Gonzalez J, Pedreira J. Hepatitis C and HIV infection: Biological, clinical, and therapeutic implications. J Hepatol 1999; 31 Suppl 1:119123.
  • 5
    Sherman K, Rouster S, Chung R, Rajicic N. Hepatitis C Prevalence in HIV-infected patients: A cross sectional analysis of the US Adult Clinical Trials Group. Presentation at the 10th International Symposium on Viral Hepatitis and Liver Disease: Atlanta, GA. 2000.
  • 6
    Staples CT Jr, RimLand D, Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The effect of coinfection on survival [see comments]. Clin Infect Dis 1999; 29:150154.
  • 7
    Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. [see comments]. N Engl J Med 1997; 337:725733.
  • 8
    McGovern B, Bica I, Dhar R, Stone D, Snydman D. Increasing mortality fromend stage liver disease secondary to hepatitis C in patients with human immunodeficiency virus infection. Presented at the 37th Conference of the Infectious Diseases Society of America Annual Meeting: Philadelphia, PA. 1999.
  • 9
    Soriano V, Garcia-Samaniego J, Gutierrez M, Bravo R, Gonzalez-Lahoz J. High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in Spain [letter]. J Infect 1994; 28:100102.
  • 10
    Sheikh AM, Wolf DC, Lebovics E, Goldberg R, Horowitz HW. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. Transplantation 1999; 68:307309.
  • 11
    Sheppard H, Ascher M. The natural history and pathogenesis of HIV infection. Ann Rev Microbiol 1992; 46:533564.
  • 12
    Karon J, Rosenberg P, McQuillan G, Khare M, Gwinn M, Petersen L. Prevalence of HIV infection in the United States. JAMA 1996; 276:16.
  • 13
    Enger C, Graham N, Peng Y. Survival from early, intermediate, and late stages of HIV infection. JAMA 1996; 275:13291334.
  • 14
    Prevention CFDCa. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47:139.
  • 15
    Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquire Immun Deficiency Synd 1993; 6:602610.
  • 16
    Gordon S, Reddy R, Gould E. The spectrum of liver disease in the acquired immunodeficiency syndrome. J Hepatol 1986; 2:475484.
  • 17
    Rusti V, Hoofnagle J, Gerin J. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:795797.
  • 18
    Andrieu JM, Even P, Venet A, Tourani JM, Stern M, Lowenstein W, et al. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin Immunol Immunopathol 1988; 47:18198.
  • 19
    Baum KF. Immunosuppression in HIV-infected transplant recipients. [letter; comment]. Clin Infect Dis 1992; 14:622623.
  • 20
    Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996; 124:654663.
  • 21
    Karpas A, Lowdell M, Jacobson SK, Hill F. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc Nat Acad Sci U S A 1992; 89:83518355.
  • 22
    Levy R, Jais JP, Tourani JM, Even P, Andrieu JM. Long-term follow-up of HIV positive asymptomatic patients having received cyclosporin A. Adv Exp Med Biol 1995; 374:229234.
  • 23
    Martin LN, Murphey-Corb M, Mack P, Baskin GB, Pantaleo G, Vaccarezza M, et al. Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys. J Infect Dis 1997; 176:374383.
  • 24
    Schwarz A, Offermann G, Keller F, Bennhold I, L'Age-Stehr J, Krause PH, et al. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation: Data on four cases and review of the literature. [see comments]. Transplantation 1993; 55:95103.
  • 25
    Phillips A, Wainberg MA, Coates R, Klein M, Rachlis A, Read S, et al. Cyclosporine-induced deterioration in patients with AIDS. Canada Med Assoc J 1989; 140:14561460.
  • 26
    Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE. Transplantation in HIV+ patients. Transplantation 1990; 49:354358.
  • 27
    Dummer JS, Erb S, Breinig MK, Ho M, Rinaldo CR, Gupta P, et al. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989; 47:134140.
  • 28
    Prachalias A, Anton P, Taylor C, Srinivasan P, Muiesan P, Wendon J, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72:16841688.
  • 29
    Bouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994; 19:854859.
  • 30
    Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998; 42:744749.